Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.357 USD | -2.95% | +11.20% | -66.23% |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.29M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.26
x | P/E ratio 2025 * |
-0.38
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.18% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | -2.67% | ||
1 week | +11.20% | ||
Current month | -13.72% | ||
1 month | -19.82% | ||
3 months | -25.30% | ||
6 months | -74.71% | ||
Current year | -66.23% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 4.357 | -2.95% | 22 389 |
24-05-17 | 4.49 | +4.42% | 8,041 |
24-05-16 | 4.3 | -6.55% | 11,333 |
24-05-15 | 4.601 | +13.33% | 55,693 |
24-05-14 | 4.06 | +3.31% | 34,115 |
Delayed Quote Nasdaq, May 20, 2024 at 11:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.23% | 2.29M | |
+39.40% | 50.93B | |
-0.22% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.95% | 26.02B | |
-22.24% | 18.9B | |
+8.81% | 13.21B | |
+24.56% | 12.17B | |
+29.74% | 12.16B |
- Stock Market
- Equities
- WINT Stock